FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3173585514> ?p ?o ?g. }

• W3173585514 endingPage "330" @default.
• W3173585514 startingPage "321" @default.
• W3173585514 abstract "Purpose: Inflammation of the ocular surface is central to dry eye disease (DED). The anti-inflammatory agent phospho-sulindac (PS) at a high dose was efficacious against DED in a rabbit model. We assessed the dose, formulation and structure dependence of PS's effect. Methods: In rabbits with concanavalin A-induced DED we evaluated a range of PS concentrations (0.05%-1.6%) and dosing frequencies, assessed the duration of its effect with PS in 2 solution formulations and one emulsion formulation, and compared the efficacy of PS to that of sulindac, and of the structurally similar phospho-ibuprofen amide. We determined tear breakup time (TBUT) (tear stability), Schirmer's tear test (tear production), and by esthesiometry corneal sensitivity (symptoms). We also determined the biodistribution in the eye of topically applied PS. Results: PS in a solution formulation, given as eye drops q.i.d. was efficacious starting at a dose of 0.1%. The effect was apparent after 2 days of treatment and lasted at least 8 days after the last dose. Both signs (evidenced by TBUT and Schirmer's test) and symptoms (measured by corneal sensitivity) improved significantly. The best formulation was the solution formulation; a cyclodextrin-based formulation was also successful but the emulsion formulation was not. PS and its metabolites were essentially restricted to the anterior chamber of the eye. Sulindac and phospho-ibuprofen amide had no efficacy on DED. Conclusions: PS is efficacious against DED. Its effect, encompassing signs, and symptoms, are dose, formulation, and structure dependent. PS has therapeutic promise and merits further development." @default.
• W3173585514 created "2021-07-05" @default.
• W3173585514 creator A5000740867 @default.
• W3173585514 creator A5049317174 @default.
• W3173585514 creator A5061750938 @default.
• W3173585514 creator A5062418301 @default.
• W3173585514 creator A5074378902 @default.
• W3173585514 creator A5076205995 @default.
• W3173585514 date "2021-08-01" @default.
• W3173585514 modified "2023-09-23" @default.
• W3173585514 title "Phospho-Sulindac (OXT-328) Inhibits Dry Eye Disease in Rabbits: A Dose-, Formulation- and Structure-Dependent Effect" @default.
• W3173585514 cites W1522220253 @default.
• W3173585514 cites W1571566412 @default.
• W3173585514 cites W1582826863 @default.
• W3173585514 cites W1595506193 @default.
• W3173585514 cites W1965857736 @default.
• W3173585514 cites W1971274032 @default.
• W3173585514 cites W1974964199 @default.
• W3173585514 cites W1983076043 @default.
• W3173585514 cites W1988413525 @default.
• W3173585514 cites W1993050768 @default.
• W3173585514 cites W2003269720 @default.
• W3173585514 cites W2010489386 @default.
• W3173585514 cites W2023854118 @default.
• W3173585514 cites W2026225037 @default.
• W3173585514 cites W2037972678 @default.
• W3173585514 cites W2044493530 @default.
• W3173585514 cites W2044609602 @default.
• W3173585514 cites W2045141901 @default.
• W3173585514 cites W2049716037 @default.
• W3173585514 cites W2060171402 @default.
• W3173585514 cites W2070160729 @default.
• W3173585514 cites W2094975816 @default.
• W3173585514 cites W2120524750 @default.
• W3173585514 cites W2129438821 @default.
• W3173585514 cites W2162546846 @default.
• W3173585514 cites W2201322105 @default.
• W3173585514 cites W2268543367 @default.
• W3173585514 cites W2276006088 @default.
• W3173585514 cites W2324350546 @default.
• W3173585514 cites W2329950081 @default.
• W3173585514 cites W2340320857 @default.
• W3173585514 cites W2344022100 @default.
• W3173585514 cites W2416788864 @default.
• W3173585514 cites W2461465029 @default.
• W3173585514 cites W2503140016 @default.
• W3173585514 cites W2598546209 @default.
• W3173585514 cites W2614281090 @default.
• W3173585514 cites W2737725878 @default.
• W3173585514 cites W2743670010 @default.
• W3173585514 cites W2749021377 @default.
• W3173585514 cites W2753596606 @default.
• W3173585514 cites W2765242879 @default.
• W3173585514 cites W2772981746 @default.
• W3173585514 cites W2783349375 @default.
• W3173585514 cites W2788240672 @default.
• W3173585514 cites W2797027002 @default.
• W3173585514 cites W2805031563 @default.
• W3173585514 cites W2810653208 @default.
• W3173585514 cites W2907033774 @default.
• W3173585514 cites W4211044089 @default.
• W3173585514 cites W4253760541 @default.
• W3173585514 doi "https://doi.org/10.1089/jop.2019.0025" @default.
• W3173585514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34152861" @default.
• W3173585514 hasPublicationYear "2021" @default.
• W3173585514 type Work @default.
• W3173585514 sameAs 3173585514 @default.
• W3173585514 citedByCount "1" @default.
• W3173585514 countsByYear W31735855142022 @default.
• W3173585514 crossrefType "journal-article" @default.
• W3173585514 hasAuthorship W3173585514A5000740867 @default.
• W3173585514 hasAuthorship W3173585514A5049317174 @default.
• W3173585514 hasAuthorship W3173585514A5061750938 @default.
• W3173585514 hasAuthorship W3173585514A5062418301 @default.
• W3173585514 hasAuthorship W3173585514A5074378902 @default.
• W3173585514 hasAuthorship W3173585514A5076205995 @default.
• W3173585514 hasConcept C118487528 @default.
• W3173585514 hasConcept C2779944601 @default.
• W3173585514 hasConcept C71924100 @default.
• W3173585514 hasConcept C98274493 @default.
• W3173585514 hasConceptScore W3173585514C118487528 @default.
• W3173585514 hasConceptScore W3173585514C2779944601 @default.
• W3173585514 hasConceptScore W3173585514C71924100 @default.
• W3173585514 hasConceptScore W3173585514C98274493 @default.
• W3173585514 hasIssue "6" @default.
• W3173585514 hasLocation W31735855141 @default.
• W3173585514 hasLocation W31735855142 @default.
• W3173585514 hasOpenAccess W3173585514 @default.
• W3173585514 hasPrimaryLocation W31735855141 @default.
• W3173585514 hasRelatedWork W10879963 @default.
• W3173585514 hasRelatedWork W13050402 @default.
• W3173585514 hasRelatedWork W16913807 @default.
• W3173585514 hasRelatedWork W20640594 @default.
• W3173585514 hasRelatedWork W21843639 @default.
• W3173585514 hasRelatedWork W471941 @default.
• W3173585514 hasRelatedWork W6357215 @default.
• W3173585514 hasRelatedWork W9152553 @default.
• W3173585514 hasRelatedWork W20674265 @default.

• next